Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Treasury Shares (2021 - 2025)

Treace Medical Concepts (TMCI) has disclosed Treasury Shares for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 321.0% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2025, up 321.0%, and an annual FY2025 reading of $1.2 million, up 321.0% over the prior year.
  • Treasury Shares was $165513.0 for Q4 2025 at Treace Medical Concepts, up from $141572.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $165513.0 in Q4 2025 and bottomed at $1218.0 in Q4 2023.
  • Average Treasury Shares over 4 years is $49370.0, with a median of $19604.0 recorded in 2024.
  • The sharpest move saw Treasury Shares surged 2061.54% in 2024, then soared 172.8% in 2025.
  • Year by year, Treasury Shares stood at $13000.0 in 2023, then soared by 2061.54% to $281000.0 in 2024, then soared by 321.0% to $1.2 million in 2025.
  • Business Quant data shows Treasury Shares for TMCI at $1.2 million in Q4 2025, $1.1 million in Q3 2025, and $696000.0 in Q2 2025.